Publication | Closed Access

Discovery of novel 6-p-tolyl-3-(3,4,5-trimethoxybenzyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivative as a potent tubulin inhibitor with promising in vivo antitumor activity

Medicinal ChemistryMedicinePharmacological AgentVivo Antitumor ActivityPharmacotherapyAnti-cancer AgentPotent Tubulin InhibitorDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryInhibitory ActivityDrug Discovery